Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas

Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 3, 2007, Pages 400-404

  King, Deanne L ^a   Stack Jr , Brendan C ^a   Spring, Paul M ^a   Walker, Ronald ^a   Bodenner, Donald L ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INCIDENCE; OUTCOME ASSESSMENT; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; THYROID CARCINOMA; THYROID INCIDENTALOMA; THYROID SURGERY; ULTRASOUND; UNIVERSITY HOSPITAL;

ADENOMA, OXYPHILIC; CARCINOMA; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENCE; INCIDENTAL FINDINGS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; WHOLE BODY IMAGING;

EID: 34548238863     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2007.02.037     Document Type: Article

References (20)

1. Macapinlac H.A. FDG-PET in head and neck, and thyroid cancer. Chang Gung Med J 28 (2005) 284-295
2. Palmedo H., Bucerius J., Joe A., et al. Integrated PET/CT in differentiated thyroid cancer: diagnostic accuracy and impact on patient management. J Nucl Med 47 (2006) 616-624
3. Wechalekar K., Sharma B., and Cook G. PET/CT in oncology-a major advance. Clin Radiol 60 (2005) 1143-1155
4. Cohen M.S., Arslan N., Dehdashti F., et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130 (2001) 941-946
5. Mitchell J., and Parangi S. The thyroid incidentaloma: an increasingly frequent consequence of radiologic imaging. Semin Ultrasound CT MR 26 (2005) 37-46
6. Mazzaferri E.L. Management of a solitary thyroid nodule. N Engl J Med 328 (1993) 553-559
7. Mitchell J.C., Grant F., Evenson A.R., et al. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT. Surgery 138 (2005) 1166-1175
8. Larson S.M., and Robbins R. Positron emission tomography in thyroid cancer management. Semin Roentgenol 37 (2002) 169-174
9. Low S.C., Sinha A.K., and Sundram F.X. Detection of thyroid malignancy in a hot nodule by fluorine-18-fluorodeoxyglucose positron emission tomography. [see comment]. Singapore Med J 46 (2005) 304-307
10. Helal B.O., Merlet P., Toubert M.E., et al. Clinical impact of 18F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy. J Nucl Med 42 (2001) 1464-1469
11. Diehl M.R., Jörn H., Brandt-Mainz K., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicenter study. Eur J Nucl Med 28 (2001) 1671-1676
12. Ishimori T., Patel P.V., and Wahl R.L. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 46 (2005) 752-757
13. Kim T.Y., Kim W.B., Ryu J.S., et al. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 115 (2005) 1074-1078
14. Yi J.G., Marom E.M., Munden R.F., et al. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer. Radiology 236 (2005) 271-275
15. Chu Q.D., Lilien C.M., Johnson D.L., et al. Positron emission tomography (PET) positive thyroid incidentaloma: the risk of malignancy observed in a tertiary referral center. Am Surg 72 (2006) 272-275
16. Kang K.W., Kim S.K., Kang H.S., et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 88 (2003) 4100-4104
17. Chen Y.K., Ding H.J., Chen K.T., et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 25 (2005) 1421-1426
18. Sakorafas G.H., Giotakis J., and Stafyla V. Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev 31 (2005) 423-438
19. Carlini M., Giovannini C., Castaldi F., et al. High risk for microcarcinoma in thyroid benign diseases. Incidence in a one year period of total thyroidectomies. J Exp Clin Cancer Res 24 (2005) 231-236
20. Lokey J.S., Palmer R.M., and MacFie J.A. Unexpected findings during thyroid surgery in a regional community hospital: a 5-year experience of 738 consecutive cases. Am Surg 71 (2005) 911-915